August 10, 2026

NanoViricides Gets Approval for Phase II Ebola Trial in DRC, Offering Oral Treatment Option

July 28, 2026

NanoViricides Seeks Regulatory Approval for Ebola Trial of NV-387 Oral Gummies in DRC

July 22, 2026

NanoViricides Seeks Approval for Phase II Ebola Trial in DRC Amid Ongoing Outbreak